| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 ABI1 TCERG1L SH3RF1 MAP1A PHF12 NACA BCORL1 SERTAD2 NSD1 DAXX SORBS1 SRCAP LPIN3 PHF2 YEATS2 KMT2D STX5 SETD5 MDC1 TADA2B ITSN2 TNRC6A SMARCC2 GIGYF2 AKAP1 SPEN PRDM16 GAB1 | 2.27e-07 | 1356 | 149 | 29 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 ABI1 TCERG1L SH3RF1 MAP1A PHF12 NACA BCORL1 SERTAD2 NSD1 DAXX SORBS1 SRCAP LPIN3 PHF2 YEATS2 KMT2D STX5 SETD5 MDC1 TADA2B TNRC6A SMARCC2 SPEN PRDM16 GAB1 | 4.40e-07 | 1160 | 149 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | TCERG1L PHF12 NACA BCORL1 SERTAD2 NSD1 DAXX SRCAP LPIN3 PHF2 YEATS2 KMT2D SETD5 TADA2B SMARCC2 SPEN PRDM16 | 1.06e-06 | 562 | 149 | 17 | GO:0003712 |
| GeneOntologyMolecularFunction | histone binding | SPHK2 DAXX SRCAP PHC1 SCML4 PHF2 YEATS2 PHC3 SETD5 MCM3AP SMARCC2 | 5.02e-06 | 265 | 149 | 11 | GO:0042393 |
| GeneOntologyMolecularFunction | histone modifying activity | 8.79e-06 | 229 | 149 | 10 | GO:0140993 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 1.39e-05 | 7 | 149 | 3 | GO:0034485 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.86e-05 | 44 | 149 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | inositol-polyphosphate 5-phosphatase activity | 2.22e-05 | 8 | 149 | 3 | GO:0004445 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 2.22e-05 | 8 | 149 | 3 | GO:0141039 | |
| GeneOntologyMolecularFunction | phosphatidylinositol trisphosphate phosphatase activity | 6.43e-05 | 11 | 149 | 3 | GO:0034594 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | NACA SERTAD2 DAXX SRCAP LPIN3 PHF2 KMT2D TADA2B SMARCC2 PRDM16 | 9.51e-05 | 303 | 149 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.10e-04 | 13 | 149 | 3 | GO:0046974 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 1.10e-04 | 13 | 149 | 3 | GO:0034595 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 1.40e-04 | 14 | 149 | 3 | GO:0046030 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.54e-04 | 68 | 149 | 5 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.66e-04 | 69 | 149 | 5 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.73e-04 | 15 | 149 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 1.80e-04 | 38 | 149 | 4 | GO:0043015 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.89e-04 | 71 | 149 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 3.06e-04 | 18 | 149 | 3 | GO:0035014 | |
| GeneOntologyMolecularFunction | inositol phosphate phosphatase activity | 4.23e-04 | 20 | 149 | 3 | GO:0052745 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 4.86e-04 | 49 | 149 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 5.67e-04 | 51 | 149 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 7.20e-04 | 143 | 149 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 7.56e-04 | 55 | 149 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | actin binding | SHROOM3 MAP1A INPPL1 WASHC1 SYNPO2L SORBS1 SPATA31C1 WASH6P WASH3P MAP1S TNS1 | 9.55e-04 | 479 | 149 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.05e-03 | 60 | 149 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 1.05e-03 | 103 | 149 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity | 1.13e-03 | 7 | 149 | 2 | GO:0052659 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.15e-03 | 105 | 149 | 5 | GO:0008170 | |
| GeneOntologyMolecularFunction | chromatin binding | ATF5 POLD1 SMC4 NSD1 MBD6 PHC1 SCML4 PHC3 SALL1 MCM3AP TADA2B AUTS2 SMARCC2 PRDM14 | 1.29e-03 | 739 | 149 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 1.43e-03 | 30 | 149 | 3 | GO:0052866 | |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 5-phosphatase activity | 1.50e-03 | 8 | 149 | 2 | GO:0052658 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 1.50e-03 | 8 | 149 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.69e-03 | 229 | 149 | 7 | GO:0003714 | |
| GeneOntologyMolecularFunction | inositol tetrakisphosphate phosphatase activity | 1.92e-03 | 9 | 149 | 2 | GO:0052743 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 2.06e-03 | 34 | 149 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 2.39e-03 | 10 | 149 | 2 | GO:0004439 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 2.39e-03 | 10 | 149 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.61e-03 | 316 | 149 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.77e-03 | 78 | 149 | 4 | GO:0008080 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 2.82e-03 | 320 | 149 | 8 | GO:0001227 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 2.84e-03 | 129 | 149 | 5 | GO:0035591 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 3.06e-03 | 39 | 149 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 3.16e-03 | 326 | 149 | 8 | GO:0001217 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate phosphatase activity | 3.48e-03 | 12 | 149 | 2 | GO:0106019 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SHROOM3 ABI1 ATF5 MAP1A INPPL1 WASHC1 SYNPO2L OBSCN DAXX SORBS1 SPATA31C1 WASH6P WASH3P MAP1S BRCA2 AKAP1 TNS1 | 3.48e-03 | 1099 | 149 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 4.09e-03 | 13 | 149 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RABEP2 RALGAPA1 ABI1 GBF1 STARD8 WASHC1 OBSCN DAXX SSPOP AKT1S1 ASAP1 WASH6P WASH3P ARHGAP31 LPA ITSN2 TNK2 MAPK7 ITIH6 PRDM14 | 4.41e-03 | 1418 | 149 | 20 | GO:0030234 |
| GeneOntologyMolecularFunction | methyltransferase activity | 5.34e-03 | 213 | 149 | 6 | GO:0008168 | |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 1.60e-06 | 79 | 148 | 7 | GO:0034394 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SPHK2 JADE2 TAF1C BCORL1 NSD1 DAXX SRCAP PRDM2 PHC1 PHF2 YEATS2 KMT2D BRCA2 SETD5 MCM3AP MDC1 TADA2B SMARCC2 TAF4 PRDM16 PRDM14 TET3 | 2.68e-06 | 999 | 148 | 22 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | SPHK2 JADE2 NSD1 DAXX SRCAP PRDM2 PHC1 PHF2 YEATS2 KMT2D BRCA2 SETD5 MCM3AP TADA2B SMARCC2 PRDM16 PRDM14 TET3 | 6.32e-06 | 741 | 148 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | SPHK2 JADE2 BCORL1 NSD1 DAXX SRCAP PRDM2 PHC1 PHF2 YEATS2 KMT2D BRCA2 SETD5 MCM3AP MDC1 TADA2B SMARCC2 PRDM16 PRDM14 TET3 | 6.56e-06 | 896 | 148 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 7.13e-06 | 6 | 148 | 3 | GO:1904109 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | RALGAPA1 ZBTB2 MAGEL2 ATF5 PHF12 NACA BCORL1 NSD1 CC2D1A DAXX HES3 PRDM2 PHC1 SCML4 YEATS2 MLXIPL PHC3 SALL1 ZNF608 SETD5 SMARCC2 SPEN IRX2 PRDM16 PRDM14 | 2.03e-05 | 1399 | 148 | 25 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | RALGAPA1 ZBTB2 MAGEL2 ATF5 PHF12 NACA BCORL1 NSD1 CC2D1A DAXX HES3 PRDM2 PHC1 SCML4 YEATS2 MLXIPL PHC3 SALL1 ZNF608 SETD5 SMARCC2 SPEN IRX2 PRDM16 PRDM14 | 2.40e-05 | 1413 | 148 | 25 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of cholesterol import | 2.95e-05 | 9 | 148 | 3 | GO:0060620 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell surface | 3.20e-05 | 51 | 148 | 5 | GO:2000008 | |
| GeneOntologyBiologicalProcess | polar body extrusion after meiotic divisions | 4.19e-05 | 10 | 148 | 3 | GO:0040038 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell surface | 5.26e-05 | 29 | 148 | 4 | GO:2000010 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | RALGAPA1 ZBTB2 MAGEL2 PHF12 NACA BCORL1 NSD1 CC2D1A DAXX HES3 PRDM2 YEATS2 MLXIPL SALL1 ZNF608 SMARCC2 SPEN IRX2 PRDM16 PRDM14 | 6.57e-05 | 1053 | 148 | 20 | GO:0000122 |
| GeneOntologyBiologicalProcess | meiotic cytokinesis | 9.82e-05 | 13 | 148 | 3 | GO:0033206 | |
| GeneOntologyBiologicalProcess | retrograde transport, endosome to Golgi | 1.36e-04 | 109 | 148 | 6 | GO:0042147 | |
| GeneOntologyBiologicalProcess | cholesterol import | 1.89e-04 | 16 | 148 | 3 | GO:0070508 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 2.10e-04 | 41 | 148 | 4 | GO:0051125 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to plasma membrane | 2.18e-04 | 76 | 148 | 5 | GO:0061951 | |
| GeneOntologyCellularComponent | chromatin | SPHK2 ATF5 JADE2 PHF12 NSD1 HLX DAXX HES3 MLXIP TEAD3 SRCAP PHC1 YEATS2 MLXIPL FOXB1 SALL1 ZBED4 SETD5 TADA2B ZFHX2 SWI5 SMARCC2 MTBP TAF4 IRX2 | 5.20e-05 | 1480 | 150 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | WASH complex | 1.55e-04 | 15 | 150 | 3 | GO:0071203 | |
| GeneOntologyCellularComponent | BLOC-1 complex | 2.73e-04 | 18 | 150 | 3 | GO:0031083 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ATF5 POLD1 PHF12 TAF1C NSD1 NPIPA1 MLXIP SRCAP PHC1 MLXIPL PHC3 KMT2D SALL1 BRCA2 SETD5 CDK13 MCM3AP SWI5 SMARCC2 AFF1 TAF4 SNRNP200 | 3.37e-04 | 1377 | 150 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | exocyst | 4.38e-04 | 21 | 150 | 3 | GO:0000145 | |
| GeneOntologyCellularComponent | BLOC complex | 5.77e-04 | 23 | 150 | 3 | GO:0031082 | |
| Domain | NPIP | 7.20e-10 | 14 | 151 | 6 | IPR009443 | |
| Domain | SET | 1.81e-06 | 46 | 151 | 6 | SM00317 | |
| Domain | DUF4599 | 1.93e-06 | 12 | 151 | 4 | PF15371 | |
| Domain | DUF4599 | 1.93e-06 | 12 | 151 | 4 | IPR027970 | |
| Domain | SET_dom | 3.00e-06 | 50 | 151 | 6 | IPR001214 | |
| Domain | SET | 3.00e-06 | 50 | 151 | 6 | PS50280 | |
| Domain | ZF_FCS | 1.02e-05 | 6 | 151 | 3 | PS51024 | |
| Domain | SH3 | SHANK1 ABI1 SH3RF1 TSPOAP1 OBSCN SORBS1 ASAP1 MYO15B ITSN2 TNK2 | 1.05e-05 | 216 | 151 | 10 | SM00326 |
| Domain | SH3 | SHANK1 ABI1 SH3RF1 TSPOAP1 OBSCN SORBS1 ASAP1 MYO15B ITSN2 TNK2 | 1.05e-05 | 216 | 151 | 10 | PS50002 |
| Domain | SH3_domain | SHANK1 ABI1 SH3RF1 TSPOAP1 OBSCN SORBS1 ASAP1 MYO15B ITSN2 TNK2 | 1.24e-05 | 220 | 151 | 10 | IPR001452 |
| Domain | SET | 1.92e-05 | 41 | 151 | 5 | PF00856 | |
| Domain | IPPc | 5.96e-05 | 10 | 151 | 3 | IPR000300 | |
| Domain | IPPc | 5.96e-05 | 10 | 151 | 3 | SM00128 | |
| Domain | RAI2/SOBP | 6.49e-05 | 2 | 151 | 2 | IPR026092 | |
| Domain | SOBP | 6.49e-05 | 2 | 151 | 2 | PF15279 | |
| Domain | MAP1 | 1.94e-04 | 3 | 151 | 2 | IPR026074 | |
| Domain | SAM_1 | 2.24e-04 | 68 | 151 | 5 | PF00536 | |
| Domain | fn3 | 3.52e-04 | 162 | 151 | 7 | PF00041 | |
| Domain | PHD | 3.54e-04 | 75 | 151 | 5 | PF00628 | |
| Domain | SH3_9 | 4.25e-04 | 78 | 151 | 5 | PF14604 | |
| Domain | Znf_PHD-finger | 4.50e-04 | 79 | 151 | 5 | IPR019787 | |
| Domain | Znf_FCS | 6.39e-04 | 5 | 151 | 2 | IPR012313 | |
| Domain | SH3_2 | 6.65e-04 | 86 | 151 | 5 | PF07653 | |
| Domain | SH3_2 | 6.65e-04 | 86 | 151 | 5 | IPR011511 | |
| Domain | SAM | 7.38e-04 | 88 | 151 | 5 | SM00454 | |
| Domain | FN3 | 7.77e-04 | 185 | 151 | 7 | SM00060 | |
| Domain | PHD | 7.77e-04 | 89 | 151 | 5 | SM00249 | |
| Domain | Znf_PHD | 8.60e-04 | 91 | 151 | 5 | IPR001965 | |
| Domain | SAM_DOMAIN | 1.04e-03 | 95 | 151 | 5 | PS50105 | |
| Domain | ZF_PHD_2 | 1.04e-03 | 95 | 151 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.09e-03 | 96 | 151 | 5 | PS01359 | |
| Domain | SAM | 1.15e-03 | 97 | 151 | 5 | IPR001660 | |
| Domain | - | 1.18e-03 | 26 | 151 | 3 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 1.18e-03 | 26 | 151 | 3 | PF03372 | |
| Domain | FN3 | 1.19e-03 | 199 | 151 | 7 | PS50853 | |
| Domain | Znf_FYVE_PHD | 1.25e-03 | 147 | 151 | 6 | IPR011011 | |
| Domain | Endo/exonuclease/phosphatase | 1.31e-03 | 27 | 151 | 3 | IPR005135 | |
| Domain | FN3_dom | 1.58e-03 | 209 | 151 | 7 | IPR003961 | |
| Domain | - | 1.70e-03 | 106 | 151 | 5 | 1.10.150.50 | |
| Domain | Zinc_finger_PHD-type_CS | 1.90e-03 | 65 | 151 | 4 | IPR019786 | |
| Domain | FHA_DOMAIN | 1.97e-03 | 31 | 151 | 3 | PS50006 | |
| Domain | SH3_1 | 2.19e-03 | 164 | 151 | 6 | PF00018 | |
| Domain | RNaseH-like_dom | 2.36e-03 | 69 | 151 | 4 | IPR012337 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPHK2 SHROOM3 GBF1 SH3RF1 PHF12 INPPL1 OBSCN NSD1 CC2D1A MLXIP SRCAP MBD6 GGA3 LPIN3 ESRP2 NHSL1 KMT2D MAP1S ZBED4 SETD5 CDK13 MCM3AP ZNF398 TNK2 SNX15 SNX11 SNAPC4 SPEN PRDM16 CEP170B WNK2 ZNF687 | 7.12e-17 | 1105 | 160 | 32 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SHROOM3 MAGEL2 GBF1 ATF5 MAP1A TSPOAP1 INPP5D INPPL1 PRX ASAP1 GGA3 PHC3 SALL1 MAP1S ARHGAP31 MDC1 AFF1 TNK2 SPEN WNK2 GAB1 | 1.05e-15 | 430 | 160 | 21 | 35044719 |
| Pubmed | SHANK1 SH3RF1 MAP1A JADE2 DAXX SORBS1 ASAP1 ARHGAP31 MCM3AP ITSN2 TNRC6A GIGYF2 TNK2 WASH2P MAPK7 TNS1 SNRNP200 WNK2 GAB1 | 1.36e-12 | 486 | 160 | 19 | 20936779 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SEC16B GBF1 PHF12 DAXX CHAMP1 ADARB1 AKT1S1 PRDM2 YEATS2 PHC3 KMT2D MAP1S CDK13 MDC1 SMARCC2 GIGYF2 AFF1 PROSER2 SNAPC4 AKAP1 SPEN SNRNP200 ZNF687 | 1.47e-12 | 774 | 160 | 23 | 15302935 |
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 1.94e-12 | 5 | 160 | 5 | 11701968 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOBP PHF12 BCORL1 PROSER1 MBD6 PRDM2 KMT2D SALL1 ZNF608 MCM3AP MDC1 AUTS2 SMARCC2 TAF4 SPEN PRDM16 | 8.99e-12 | 351 | 160 | 16 | 38297188 |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 1.16e-11 | 6 | 160 | 5 | 18159949 | |
| Pubmed | TSPOAP1 SORBS1 MLXIP ASAP1 GGA3 KLHL29 YEATS2 ZBED4 SETD5 ZFR2 MCM3AP ITSN2 GIGYF2 SPEN TET3 CEP170B | 8.09e-11 | 407 | 160 | 16 | 12693553 | |
| Pubmed | SOBP PHF12 NACA BCORL1 CC2D1A PROSER1 TEAD3 SRCAP MBD6 PRDM2 PHF2 YEATS2 PHC3 KMT2D SALL1 ZNF608 MDC1 TADA2B TNRC6A AUTS2 SMARCC2 GIGYF2 N4BP1 TAF4 SPEN PRDM16 RAI2 ZNF687 | 8.75e-11 | 1429 | 160 | 28 | 35140242 | |
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 32879135 | ||
| Pubmed | RALGAPA1 SHROOM3 JADE2 PHF12 NACA SERTAD2 CHAMP1 GGA3 FBXL7 ZNF608 ARHGAP31 MDC1 TNRC6A AUTS2 IGSF9 WNK2 ZNF687 | 4.50e-10 | 529 | 160 | 17 | 14621295 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 NES SHROOM3 ABI1 GBF1 SH3RF1 INPPL1 CC2D1A SORBS1 MLXIP AKT1S1 LPIN3 NHSL1 MLXIPL STX5 SIK2 GIGYF2 PROSER2 AKAP1 CEP170B GAB1 | 5.48e-10 | 861 | 160 | 21 | 36931259 |
| Pubmed | PHF12 BCORL1 CHAMP1 PRDM2 PHC1 YEATS2 PHC3 KMT2D SALL1 ZNF608 BRCA2 TNRC6A GIGYF2 AKAP1 ZNF687 | 1.13e-09 | 418 | 160 | 15 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PHF12 BCORL1 NSD1 DAXX SRCAP CHAMP1 PRDM2 PHC1 PHF2 PHC3 MDC1 TADA2B SMARCC2 TAF4 SNAPC4 SPEN | 2.49e-08 | 608 | 160 | 16 | 36089195 |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 2.98e-08 | 8 | 160 | 4 | 10655549 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PHF12 TAF1C BCORL1 NSD1 MLXIP TEAD3 SRCAP CHAMP1 PRDM2 PHF2 YEATS2 MLXIPL PHC3 KMT2D ZBED4 CDK13 MDC1 TADA2B TAF4 SPEN TET3 SNRNP200 ZNF687 | 3.07e-08 | 1294 | 160 | 23 | 30804502 |
| Pubmed | EP400P1 ZBTB2 MAP1A POLD1 PHF12 TAF1C SRCAP CHAMP1 PHF2 YEATS2 ZNF608 SETD5 MCM3AP TADA2B TNRC6A SMARCC2 TAF4 IRX2 PRDM16 CEP170B ZNF687 | 4.99e-08 | 1116 | 160 | 21 | 31753913 | |
| Pubmed | Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination. | 8.87e-08 | 10 | 160 | 4 | 23452853 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 EP400P1 SHROOM3 JADE2 SOBP OBSCN ADARB1 SSPOP KLHL29 PHF2 YEATS2 ZNF608 SETD5 CDK13 AUTS2 ZFHX2 AFF1 TNK2 IGSF9 TAF4 TET3 CEP170B IL6R WNK2 | 9.26e-08 | 1489 | 160 | 24 | 28611215 |
| Pubmed | WASH Regulates Glucose Homeostasis by Facilitating Glut2 Receptor Recycling in Pancreatic β-Cells. | 9.56e-08 | 3 | 160 | 3 | 30425062 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 38086439 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 25225459 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SH3RF1 MAP1A INPPL1 BCORL1 DAXX SORBS1 SRCAP YEATS2 SALL1 BRCA2 MCM3AP TNRC6A SPEN CEP170B GAB1 | 1.04e-07 | 588 | 160 | 15 | 38580884 |
| Pubmed | NSD1 DAXX ADARB1 LPIN3 KMT2D MDC1 SMARCC2 GIGYF2 PRDM16 SNRNP200 | 1.48e-07 | 234 | 160 | 10 | 36243803 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | MAP1A YEATS2 KMT2D ARHGAP31 MCM3AP TNRC6A GIGYF2 SPEN CEP170B | 2.02e-07 | 184 | 160 | 9 | 32908313 |
| Pubmed | SMC4 NSD1 CC2D1A SRCAP AP3B1 CHAMP1 GGA3 YEATS2 KMT2D MDC1 GIGYF2 TAF4 SPEN SNRNP200 | 2.84e-07 | 549 | 160 | 14 | 38280479 | |
| Pubmed | ZBTB2 NACA BCORL1 SMC4 MUC16 PHC1 YEATS2 SALL1 MDC1 SMARCC2 SPEN PRDM14 | 3.41e-07 | 396 | 160 | 12 | 26687479 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 32492429 | ||
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 3.81e-07 | 4 | 160 | 3 | 18055785 | |
| Pubmed | The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance. | 3.81e-07 | 4 | 160 | 3 | 31167970 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 23275443 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 22718907 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 24886983 | ||
| Pubmed | SHROOM3 ABI1 POLD1 PHF12 TAF1C NACA SMC4 NSD1 DAXX AP3B1 PHF2 PHC3 SETD5 CDK13 MDC1 TADA2B ITSN2 TNRC6A TAF4 AKAP1 SPEN CEP170B ZNF687 | 4.09e-07 | 1497 | 160 | 23 | 31527615 | |
| Pubmed | 5.23e-07 | 103 | 160 | 7 | 10819331 | ||
| Pubmed | 7.20e-07 | 157 | 160 | 8 | 30186101 | ||
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 20308062 | ||
| Pubmed | Endosomal WASH and exocyst complexes control exocytosis of MT1-MMP at invadopodia. | 9.49e-07 | 5 | 160 | 3 | 24344185 | |
| Pubmed | 1.09e-06 | 225 | 160 | 9 | 12168954 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | ATF5 HLX HES3 MLXIP TEAD3 PRDM2 YEATS2 MLXIPL FOXB1 KMT2D SALL1 ZBED4 TADA2B ZNF398 ZFHX2 SNAPC4 IRX2 | 1.10e-06 | 908 | 160 | 17 | 19274049 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.15e-06 | 167 | 160 | 8 | 20362541 | |
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 1.26e-06 | 18 | 160 | 4 | 25363768 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NSD1 CC2D1A DAXX AP3B1 PHC1 PHF2 PHC3 SETD5 MDC1 SMARCC2 TAF4 SNRNP200 ZNF687 | 1.26e-06 | 533 | 160 | 13 | 30554943 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | TSPOAP1 MUC16 MLXIP NPIPA7 PRDM2 KLHL29 KMT2D MYO15B TNRC6A ZFHX2 TNS1 PRDM14 TNXB | 1.85e-06 | 552 | 160 | 13 | 10737800 |
| Pubmed | WASH complex regulates Arp2/3 complex for actin-based polar body extrusion in mouse oocytes. | 1.89e-06 | 6 | 160 | 3 | 24998208 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SHROOM3 ABI1 SH3RF1 INPPL1 CC2D1A SORBS1 ASAP1 GGA3 NHSL1 STX5 GIGYF2 N4BP1 GAB1 | 2.39e-06 | 565 | 160 | 13 | 25468996 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | BCORL1 PRDM2 YEATS2 PHC3 KMT2D SALL1 ZNF608 AUTS2 SMARCC2 PRDM16 RAI2 | 2.60e-06 | 398 | 160 | 11 | 35016035 |
| Pubmed | WASH maintains NKp46+ ILC3 cells by promoting AHR expression. | 3.30e-06 | 7 | 160 | 3 | 28589939 | |
| Pubmed | SEC16B ZBTB2 GBF1 STARD8 SH3RF1 PRX PHF2 MYO15B CDK13 N4BP1 PRDM16 SNRNP200 | 3.34e-06 | 493 | 160 | 12 | 15368895 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ESRP1 SMC4 SRCAP CHAMP1 KMT2D MCM3AP MDC1 SMARCC2 SPEN ZNF687 | 4.46e-06 | 341 | 160 | 10 | 32971831 |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 27927957 | ||
| Pubmed | A FAM21-containing WASH complex regulates retromer-dependent sorting. | 5.26e-06 | 8 | 160 | 3 | 19922874 | |
| Pubmed | RALGAPA1 SHROOM3 GBF1 SH3RF1 SORBS1 TEAD3 AKT1S1 MAP1S TNRC6A GIGYF2 CEP170B | 7.65e-06 | 446 | 160 | 11 | 24255178 | |
| Pubmed | RNF2 is recruited by WASH to ubiquitinate AMBRA1 leading to downregulation of autophagy. | 7.87e-06 | 9 | 160 | 3 | 24980959 | |
| Pubmed | 8.07e-06 | 102 | 160 | 6 | 9734811 | ||
| Pubmed | Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. | 1.08e-05 | 30 | 160 | 4 | 12522270 | |
| Pubmed | WASH inhibits autophagy through suppression of Beclin 1 ubiquitination. | 1.12e-05 | 10 | 160 | 3 | 23974797 | |
| Pubmed | SHROOM3 NACA SMC4 CC2D1A HES3 FBXL7 STX5 BRCA2 MDC1 PROSER2 AKAP1 SNRNP200 INPP5J ZNF687 | 1.12e-05 | 754 | 160 | 14 | 35906200 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZBTB2 ATF5 JADE2 TAF1C SERTAD2 DAXX MLXIP TEAD3 PHF2 FOXB1 BRCA2 ZNF398 SNAPC4 SPEN PRDM14 | 1.42e-05 | 877 | 160 | 15 | 20211142 |
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 26965651 | ||
| Pubmed | The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex. | 2.04e-05 | 12 | 160 | 3 | 19922875 | |
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 2.04e-05 | 12 | 160 | 3 | 27824329 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 27390154 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25143390 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22354987 | ||
| Pubmed | Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2. | 2.10e-05 | 2 | 160 | 2 | 38309262 | |
| Pubmed | WASH and the Arp2/3 complex regulate endosome shape and trafficking. | 2.10e-05 | 2 | 160 | 2 | 20175130 | |
| Pubmed | MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells. | 2.10e-05 | 2 | 160 | 2 | 29282201 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36238894 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19839650 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12885297 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19829082 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27401076 | ||
| Pubmed | Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. | 2.10e-05 | 2 | 160 | 2 | 16644671 | |
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 2.10e-05 | 2 | 160 | 2 | 11586358 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26910886 | ||
| Pubmed | An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. | 2.10e-05 | 2 | 160 | 2 | 20711167 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37090731 | ||
| Pubmed | Regional bias of tumor suppressor gene mutations of STARD8 and WNK2 in colon cancers. | 2.10e-05 | 2 | 160 | 2 | 38091885 | |
| Pubmed | Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma. | 2.10e-05 | 2 | 160 | 2 | 31686349 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33339518 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27404344 | ||
| Pubmed | 2.11e-05 | 72 | 160 | 5 | 36376293 | ||
| Pubmed | 2.46e-05 | 124 | 160 | 6 | 20850016 | ||
| Pubmed | 3.22e-05 | 130 | 160 | 6 | 12421765 | ||
| Pubmed | 3.36e-05 | 131 | 160 | 6 | 31006538 | ||
| Pubmed | 3.64e-05 | 268 | 160 | 8 | 33640491 | ||
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 3.74e-05 | 81 | 160 | 5 | 20697350 | |
| Pubmed | PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. | 3.83e-05 | 41 | 160 | 4 | 22325352 | |
| Pubmed | Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting. | 4.17e-05 | 15 | 160 | 3 | 29893854 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 35013309 | ||
| Pubmed | SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase. | 6.29e-05 | 3 | 160 | 2 | 15492005 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 31782782 | ||
| Pubmed | The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma. | 6.29e-05 | 3 | 160 | 2 | 26522722 | |
| Pubmed | Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo). | 6.29e-05 | 3 | 160 | 2 | 11402314 | |
| Pubmed | Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells. | 6.29e-05 | 3 | 160 | 2 | 24966940 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 31836657 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 18829867 | ||
| Pubmed | POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66. | 6.29e-05 | 3 | 160 | 2 | 20926658 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 30190612 | ||
| Interaction | TOP3B interactions | SPHK2 SHROOM3 GBF1 SH3RF1 PHF12 INPPL1 OBSCN NSD1 CC2D1A MLXIP SRCAP MBD6 GGA3 LPIN3 ESRP2 NHSL1 KMT2D MAP1S ZBED4 SETD5 CDK13 MCM3AP MDC1 ZNF398 TNK2 SNX15 SNX11 SNAPC4 SPEN PRDM16 CEP170B WNK2 ZNF687 | 1.61e-08 | 1470 | 154 | 33 | int:TOP3B |
| Interaction | TLE3 interactions | BCORL1 HLX PROSER1 PHC3 FOXB1 KMT2D SALL1 ZNF608 BRCA2 MCM3AP TNRC6A AUTS2 SMARCC2 TAF4 SPEN | 2.05e-07 | 376 | 154 | 15 | int:TLE3 |
| Interaction | TERF2IP interactions | ZBTB2 POLD1 NSD1 SRCAP CHAMP1 PRX PHC1 YEATS2 PHC3 ZNF608 BRCA2 CDK13 MDC1 TADA2B SMARCC2 TAF4 SPEN ZNF687 | 2.39e-07 | 552 | 154 | 18 | int:TERF2IP |
| Interaction | ASF1A interactions | BCORL1 NSD1 SRCAP PRDM2 PHF2 YEATS2 KMT2D BRCA2 MDC1 SMARCC2 SPEN ZNF687 | 4.94e-07 | 249 | 154 | 12 | int:ASF1A |
| Interaction | YWHAH interactions | RALGAPA1 NES SHROOM3 ABI1 GBF1 SH3RF1 INPPL1 RPS6KB2 CC2D1A SORBS1 MLXIP AKT1S1 LPIN3 NHSL1 MLXIPL STX5 SIK2 GIGYF2 MTBP PROSER2 MAPK7 AKAP1 CEP170B WNK2 GAB1 | 9.69e-07 | 1102 | 154 | 25 | int:YWHAH |
| Interaction | NUP43 interactions | POLD1 PHF12 NSD1 SRCAP CHAMP1 PRDM2 PHF2 YEATS2 PHC3 KMT2D ZNF608 BRCA2 MCM3AP MDC1 TAF4 SPEN SNRNP200 ZNF687 | 1.44e-06 | 625 | 154 | 18 | int:NUP43 |
| Interaction | BICD1 interactions | NES SHROOM3 CC2D1A SORBS1 MLXIP GGA3 ITSN2 TNRC6A GIGYF2 CEP170B | 2.32e-05 | 250 | 154 | 10 | int:BICD1 |
| Interaction | SOX7 interactions | 3.92e-05 | 82 | 154 | 6 | int:SOX7 | |
| Interaction | ETS1 interactions | 4.05e-05 | 121 | 154 | 7 | int:ETS1 | |
| Interaction | H3-4 interactions | JADE2 PHF12 NSD1 DAXX CHAMP1 PRDM2 PHF2 PHC3 CDK13 TNRC6A AFF1 TAF4 PRDM16 | 4.16e-05 | 448 | 154 | 13 | int:H3-4 |
| Interaction | GSC interactions | 5.48e-05 | 87 | 154 | 6 | int:GSC | |
| Interaction | KLF3 interactions | 6.63e-05 | 228 | 154 | 9 | int:KLF3 | |
| Interaction | H2BC21 interactions | PHF12 BCORL1 OBSCN NSD1 DAXX SRCAP CHAMP1 ADARB1 PRDM2 PHC1 PHF2 YEATS2 MDC1 SMARCC2 MTBP ZNF687 | 8.81e-05 | 696 | 154 | 16 | int:H2BC21 |
| Interaction | CLTB interactions | 9.04e-05 | 185 | 154 | 8 | int:CLTB | |
| Interaction | RCOR1 interactions | PHF12 BCORL1 SMC4 YEATS2 KMT2D SALL1 BRCA2 SMARCC2 GIGYF2 AKAP1 SPEN PRDM16 ZNF687 | 1.11e-04 | 494 | 154 | 13 | int:RCOR1 |
| Interaction | H3C3 interactions | PHF12 BCORL1 NSD1 DAXX SRCAP CHAMP1 PRDM2 PHC1 PHF2 PHC3 MDC1 SMARCC2 SPEN | 1.14e-04 | 495 | 154 | 13 | int:H3C3 |
| Cytoband | 9q21.32 | 3.86e-05 | 19 | 160 | 3 | 9q21.32 | |
| Cytoband | 16p13.11 | 6.99e-05 | 23 | 160 | 3 | 16p13.11 | |
| Cytoband | 19q13.3 | 2.01e-04 | 82 | 160 | 4 | 19q13.3 | |
| Cytoband | 16p12.2 | 2.96e-04 | 37 | 160 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 3.58e-04 | 172 | 160 | 5 | chr16p12 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 2.15e-08 | 16 | 102 | 5 | 14 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.89e-05 | 34 | 102 | 4 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.12e-04 | 17 | 102 | 3 | 1197 | |
| GeneFamily | Sterile alpha motif domain containing | 1.40e-04 | 88 | 102 | 5 | 760 | |
| GeneFamily | PHD finger proteins | 1.56e-04 | 90 | 102 | 5 | 88 | |
| GeneFamily | Fibronectin type III domain containing | 2.92e-04 | 160 | 102 | 6 | 555 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.66e-04 | 25 | 102 | 3 | 775 | |
| GeneFamily | Phosphoinositide phosphatases | 7.68e-04 | 32 | 102 | 3 | 1079 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.33e-03 | 53 | 102 | 3 | 532 | |
| GeneFamily | Cadherin related | 4.06e-03 | 17 | 102 | 2 | 24 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | DXO SPHK2 ATF5 TAF1C NPIPB3 TEAD3 SRCAP WASH3P KMT2D SETD5 TNK2 SNAPC4 | 1.07e-06 | 338 | 158 | 12 | M17094 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 1.86e-06 | 184 | 158 | 9 | M19988 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | SHANK1 ZFAT ST20-AS1 SERTAD2 MLXIP MBD6 AP3B1 PPM1J ASAP1 MAPK7 SPEN TET3 | 1.40e-05 | 435 | 158 | 12 | M41115 |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 2.52e-05 | 195 | 158 | 8 | M7382 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 2.74e-05 | 97 | 158 | 6 | M14698 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN | 3.03e-05 | 200 | 158 | 8 | M7305 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#2 | SPHK2 SHROOM3 ZBTB2 TCERG1L NSD1 PROSER1 PRX ZNF608 SETD5 ZNF398 IGSF9 IRX2 PRDM14 ZNF687 | 9.98e-07 | 387 | 155 | 14 | ratio_EB-blastocyst_vs_EB-fibro_2500_K2 |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-07 | 189 | 160 | 8 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 3.78e-06 | 178 | 160 | 7 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 3.92e-06 | 179 | 160 | 7 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 5.04e-06 | 186 | 160 | 7 | 6259f0f2d5bc863782d09a901d6be2f387d1f074 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 5.82e-06 | 124 | 160 | 6 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.85e-06 | 199 | 160 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.95e-05 | 165 | 160 | 6 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-05 | 168 | 160 | 6 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 169 | 160 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.49e-05 | 170 | 160 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.61e-05 | 171 | 160 | 6 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.61e-05 | 171 | 160 | 6 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.70e-05 | 104 | 160 | 5 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.70e-05 | 104 | 160 | 5 | 424a58b04c8b5108b70f15d8353c8e4b9db1e730 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.70e-05 | 104 | 160 | 5 | 9b05ae514437eb0c8b1b23607ae8cbc371ffa85b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 173 | 160 | 6 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 175 | 160 | 6 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 4.24e-05 | 176 | 160 | 6 | 07cde50e1c18fcc2c5028efe1a087db4ef4d4783 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.51e-05 | 178 | 160 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 179 | 160 | 6 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.59e-05 | 185 | 160 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.59e-05 | 185 | 160 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 186 | 160 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 188 | 160 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.48e-05 | 190 | 160 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 190 | 160 | 6 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 190 | 160 | 6 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.67e-05 | 191 | 160 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 6.67e-05 | 191 | 160 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.67e-05 | 191 | 160 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.67e-05 | 191 | 160 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.07e-05 | 193 | 160 | 6 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.07e-05 | 193 | 160 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.27e-05 | 194 | 160 | 6 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 194 | 160 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.27e-05 | 194 | 160 | 6 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.48e-05 | 195 | 160 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 196 | 160 | 6 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 196 | 160 | 6 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.91e-05 | 197 | 160 | 6 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.91e-05 | 197 | 160 | 6 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 197 | 160 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.91e-05 | 197 | 160 | 6 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | Sepsis-URO-Others|URO / Disease, condition lineage and cell class | 8.14e-05 | 198 | 160 | 6 | 6caab5266da666cfbe92ac1ace26ad2004e5aa09 | |
| ToppCell | Sepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class | 8.14e-05 | 198 | 160 | 6 | d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.14e-05 | 198 | 160 | 6 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.14e-05 | 198 | 160 | 6 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-05 | 199 | 160 | 6 | 14a7c4cf4bb3d43fd32ec9cc74f6625b225ffaa1 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 133 | 160 | 5 | 2ec3490cbf60152c3cece95eb566d749c9666517 | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 7.72e-06 | 197 | 153 | 9 | 4501_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.04e-06 | 198 | 153 | 9 | 4414_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 4.65e-05 | 191 | 153 | 8 | 6776_UP | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A | 4.82e-05 | 192 | 153 | 8 | 7556_UP | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 5.00e-05 | 193 | 153 | 8 | 6789_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A | 5.19e-05 | 194 | 153 | 8 | 1422_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.19e-05 | 194 | 153 | 8 | 6835_UP | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 5.38e-05 | 195 | 153 | 8 | 3715_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 5.38e-05 | 195 | 153 | 8 | 2833_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 5.58e-05 | 196 | 153 | 8 | 5577_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 5.58e-05 | 196 | 153 | 8 | 3637_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 5.58e-05 | 196 | 153 | 8 | 5624_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.78e-05 | 197 | 153 | 8 | 2285_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 5.78e-05 | 197 | 153 | 8 | 2259_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 5.78e-05 | 197 | 153 | 8 | 5843_UP | |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A | 5.99e-05 | 198 | 153 | 8 | 2432_UP | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.99e-05 | 198 | 153 | 8 | 2281_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 5.99e-05 | 198 | 153 | 8 | 7549_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 153 | 8 | 5959_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 153 | 8 | 5788_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 153 | 8 | 6968_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 153 | 8 | 2289_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 6.43e-05 | 200 | 153 | 8 | 3936_UP | |
| Disease | body surface area | RALGAPA1 SEC16B ZBTB2 ZFAT NSD1 AP3B1 SPATA31C1 KLHL29 ZNF608 SETD5 ITSN2 TNRC6A AUTS2 GIGYF2 | 4.41e-06 | 643 | 147 | 14 | EFO_0022196 |
| Disease | C-reactive protein measurement | SEC16B DCHS2 MAP1A HLX ADARB1 SSPOP YEATS2 MLXIPL SALL1 ZNF608 SETD5 LPA SMARCC2 TAF4 SNX11 SNAPC4 IL6R | 1.11e-04 | 1206 | 147 | 17 | EFO_0004458 |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.14e-04 | 50 | 147 | 4 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.23e-04 | 51 | 147 | 4 | EFO_0022331 | |
| Disease | cortical surface area measurement | RABEP2 DCHS2 PRR23A SHROOM3 ABI1 MBD6 KLHL29 NHSL1 FBXL7 ARHGAP31 MDC1 TNRC6A AUTS2 AFF1 IGSF9 TNS1 TNXB WNK2 | 1.33e-04 | 1345 | 147 | 18 | EFO_0010736 |
| Disease | tenascin-X measurement | 1.47e-04 | 4 | 147 | 2 | EFO_0802121 | |
| Disease | hypertension | 1.60e-04 | 307 | 147 | 8 | EFO_0000537 | |
| Disease | triacylglycerol 58:9 measurement | 1.74e-04 | 22 | 147 | 3 | EFO_0010443 | |
| Disease | triglycerides in LDL measurement | 1.78e-04 | 56 | 147 | 4 | EFO_0022320 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 2.04e-04 | 58 | 147 | 4 | EFO_0022338 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.40e-04 | 111 | 147 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | JT interval | 2.55e-04 | 248 | 147 | 7 | EFO_0007885 | |
| Disease | triglycerides in medium LDL measurement | 2.64e-04 | 62 | 147 | 4 | EFO_0022322 | |
| Disease | neuroimaging measurement | DXO DCHS2 PRR23A SHROOM3 MBD6 NHSL1 MLXIPL FBXL7 TNRC6A AFF1 IGSF9 ROBO3 PRDM16 TNS1 WNK2 | 3.02e-04 | 1069 | 147 | 15 | EFO_0004346 |
| Disease | monocyte percentage of leukocytes | ST20-AS1 TSPOAP1 JADE2 SERTAD2 HLX MLXIPL MAP1S MCM3AP TADA2B ITSN2 PRDM16 IL6R | 3.12e-04 | 731 | 147 | 12 | EFO_0007989 |
| Disease | sexual dimorphism measurement | RALGAPA1 SEC16B ZFAT RPS6KB2 NSD1 MLXIP TEAD3 AP3B1 SPATA31C1 KLHL29 MLXIPL SSC5D ZNF608 LPA TNRC6A | 4.31e-04 | 1106 | 147 | 15 | EFO_0021796 |
| Disease | brain measurement, neuroimaging measurement | 4.54e-04 | 550 | 147 | 10 | EFO_0004346, EFO_0004464 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.86e-04 | 276 | 147 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | neutrophil count | NES SPHK2 TSPOAP1 JADE2 INPP5D BCORL1 NSD1 HLX MLXIPL ADRB1 SALL1 TADA2B ITSN2 TNRC6A ZNF398 AFF1 TNXB | 5.43e-04 | 1382 | 147 | 17 | EFO_0004833 |
| Disease | mean platelet volume | STARD8 NACA BCORL1 SORBS1 SRCAP ASAP1 KLHL29 MLXIPL ZBED4 TNRC6A AFF1 PROSER2 PRDM16 IL6R | 5.99e-04 | 1020 | 147 | 14 | EFO_0004584 |
| Disease | testosterone measurement | DXO DCHS2 SHROOM3 STARD8 MAP1A JADE2 BCORL1 SERTAD2 SRCAP CHAMP1 GGA3 MLXIPL AUTS2 AFF1 TAF4 SLC24A1 | 6.43e-04 | 1275 | 147 | 16 | EFO_0004908 |
| Disease | obesity (implicated_via_orthology) | 7.52e-04 | 215 | 147 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 8.31e-04 | 37 | 147 | 3 | EFO_0022252 | |
| Disease | interleukin 18 receptor accessory protein measurement | 8.67e-04 | 9 | 147 | 2 | EFO_0008179 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.30e-04 | 224 | 147 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 9.52e-04 | 225 | 147 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | Eczema | 9.60e-04 | 310 | 147 | 7 | HP_0000964 | |
| Disease | Malignant neoplasm of breast | STARD8 RPS6KB2 BCORL1 OBSCN SORBS1 GGA3 KMT2D STX5 BRCA2 ITSN2 AFF1 SPEN TNS1 GAB1 | 9.86e-04 | 1074 | 147 | 14 | C0006142 |
| Disease | prostate cancer (is_marker_for) | 1.13e-03 | 156 | 147 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 1.22e-03 | 93 | 147 | 4 | C1535926 | |
| Disease | triglycerides in large LDL measurement | 1.29e-03 | 43 | 147 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.29e-03 | 43 | 147 | 3 | EFO_0022254 | |
| Disease | adipose tissue measurement | 1.47e-03 | 45 | 147 | 3 | EFO_0004764 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.47e-03 | 45 | 147 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | atopic eczema | 1.70e-03 | 252 | 147 | 6 | EFO_0000274 | |
| Disease | bilirubin measurement | 1.74e-03 | 442 | 147 | 8 | EFO_0004570 | |
| Disease | phosphatidylcholine 40:7 measurement | 1.85e-03 | 13 | 147 | 2 | EFO_0021477 | |
| Disease | asthma, response to diisocyanate | 2.02e-03 | 261 | 147 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | Autistic Disorder | 2.02e-03 | 261 | 147 | 6 | C0004352 | |
| Disease | sitting height ratio | 2.12e-03 | 51 | 147 | 3 | EFO_0007118 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.12e-03 | 51 | 147 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 2.12e-03 | 51 | 147 | 3 | EFO_0022240 | |
| Disease | coffee consumption measurement | 2.23e-03 | 182 | 147 | 5 | EFO_0006781 | |
| Disease | granulocyte percentage of myeloid white cells | 2.31e-03 | 268 | 147 | 6 | EFO_0007997 | |
| Disease | triglycerides in HDL measurement | 2.36e-03 | 53 | 147 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.36e-03 | 53 | 147 | 3 | EFO_0022286 | |
| Disease | total lipids in medium VLDL | 2.49e-03 | 54 | 147 | 3 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 2.49e-03 | 54 | 147 | 3 | EFO_0022321 | |
| Disease | monocyte count | RALGAPA1 DXO ZBTB2 ST20-AS1 TSPOAP1 JADE2 INPP5D SERTAD2 HLX MLXIPL ZNF608 LPA TADA2B ITSN2 IL6R | 2.51e-03 | 1320 | 147 | 15 | EFO_0005091 |
| Disease | triglycerides in medium VLDL measurement | 2.63e-03 | 55 | 147 | 3 | EFO_0022155 | |
| Disease | cholesterol to total lipids in large HDL percentage | 2.63e-03 | 55 | 147 | 3 | EFO_0022234 | |
| Disease | coronary artery disease | DXO SHROOM3 INPP5D SCML4 PHF2 MAP1S LPA SIK2 GIGYF2 PRDM16 TNS1 TNXB IL6R WNK2 | 2.63e-03 | 1194 | 147 | 14 | EFO_0001645 |
| Disease | triglycerides in large VLDL measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.77e-03 | 56 | 147 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 2.77e-03 | 56 | 147 | 3 | EFO_0022316 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.77e-03 | 56 | 147 | 3 | EFO_0022235 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.77e-03 | 56 | 147 | 3 | EFO_0022251 | |
| Disease | phosphatidylcholine measurement | 3.08e-03 | 284 | 147 | 6 | EFO_0010226 | |
| Disease | eosinophil count | DXO ZFAT ST20-AS1 MCIDAS INPP5D SMC4 HLX PHC1 PHC3 SALL1 SIK2 ZNF398 N4BP1 TET3 SNRNP200 TNXB | 3.12e-03 | 1488 | 147 | 16 | EFO_0004842 |
| Disease | non-high density lipoprotein cholesterol measurement | 3.13e-03 | 713 | 147 | 10 | EFO_0005689 | |
| Disease | IGF-1 measurement | 3.19e-03 | 488 | 147 | 8 | EFO_0004627 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.20e-03 | 121 | 147 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | triglycerides in VLDL measurement | 3.21e-03 | 59 | 147 | 3 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 3.21e-03 | 59 | 147 | 3 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 3.21e-03 | 59 | 147 | 3 | EFO_0022301 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 3.21e-03 | 59 | 147 | 3 | EFO_0022248 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 3.21e-03 | 59 | 147 | 3 | EFO_0022260 | |
| Disease | waist-hip ratio | SEC16B ZFAT COL15A1 NSD1 HLX AP3B1 PHC1 KLHL29 YEATS2 MLXIPL SSC5D ADRB1 TNRC6A PRDM16 | 3.34e-03 | 1226 | 147 | 14 | EFO_0004343 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.34e-03 | 200 | 147 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | metabolic syndrome | 3.34e-03 | 200 | 147 | 5 | EFO_0000195 | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.37e-03 | 60 | 147 | 3 | EFO_0022330 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 3.37e-03 | 60 | 147 | 3 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 3.37e-03 | 60 | 147 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.37e-03 | 60 | 147 | 3 | EFO_0022237 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.46e-03 | 291 | 147 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | triglycerides in small VLDL measurement | 3.53e-03 | 61 | 147 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 3.53e-03 | 61 | 147 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 3.53e-03 | 61 | 147 | 3 | EFO_0022276 | |
| Disease | puberty onset measurement | 3.60e-03 | 125 | 147 | 4 | EFO_0005677 | |
| Disease | triglycerides in small HDL measurement | 3.70e-03 | 62 | 147 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 3.70e-03 | 62 | 147 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.70e-03 | 62 | 147 | 3 | EFO_0022339 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 3.70e-03 | 62 | 147 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 3.70e-03 | 62 | 147 | 3 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 3.70e-03 | 62 | 147 | 3 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 3.70e-03 | 62 | 147 | 3 | EFO_0022299 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 3.79e-03 | 206 | 147 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 3.80e-03 | 127 | 147 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | cortical thickness | PRR23A SHROOM3 MBD6 KLHL29 NHSL1 FBXL7 SETD5 TNRC6A AUTS2 AFF1 IGSF9 TNS1 WNK2 | 3.85e-03 | 1113 | 147 | 13 | EFO_0004840 |
| Disease | free cholesterol to total lipids in medium LDL percentage | 3.87e-03 | 63 | 147 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 3.87e-03 | 63 | 147 | 3 | EFO_0022292 | |
| Disease | triglycerides in small LDL measurement | 4.22e-03 | 65 | 147 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 4.22e-03 | 65 | 147 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.22e-03 | 65 | 147 | 3 | EFO_0022230 | |
| Disease | eosinophil percentage of leukocytes | 4.30e-03 | 746 | 147 | 10 | EFO_0007991 | |
| Disease | bitter alcoholic beverage consumption measurement | 4.48e-03 | 133 | 147 | 4 | EFO_0010092 | |
| Disease | Eczema, allergic rhinitis | 4.54e-03 | 215 | 147 | 5 | EFO_0005854, HP_0000964 | |
| Disease | total lipids in large VLDL | 4.60e-03 | 67 | 147 | 3 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 4.79e-03 | 68 | 147 | 3 | EFO_0022327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLLVPASPPASLLPP | 31 | P08588 | |
| PPLPSLALPSLPMTS | 686 | Q92667 | |
| TELVLLTAAPPPPPR | 26 | Q96B36 | |
| VATSVPAPSPPLAPV | 241 | Q5H9F3 | |
| PALAPAPPSVPTLIS | 256 | Q5H9F3 | |
| PLSAPAPAPLSVPVS | 296 | Q5H9F3 | |
| APAPLSVPVSAPPLA | 301 | Q5H9F3 | |
| VPPSAPTLVLAPVPT | 321 | Q5H9F3 | |
| PTLVLAPVPTPVLAP | 326 | Q5H9F3 | |
| PAPPLAPLLPVSTVI | 286 | Q8IZP0 | |
| PPSPASAEALLPALP | 1546 | Q9Y4F5 | |
| ALVTSTLPPLPLPPM | 601 | Q14004 | |
| LPSPPSPLASLAPVA | 666 | Q9UER7 | |
| SPEEPTPLPVPLLLP | 881 | Q07912 | |
| PVSTPVALPTPALSP | 826 | O00203 | |
| VDFTALLPLEPPLPP | 71 | Q9Y2D1 | |
| LPLSLPSFDLPQPPV | 141 | Q9Y2D1 | |
| FSSAPLIPLPTPPII | 416 | Q6NXG1 | |
| TPPECLLTPLPPSAL | 341 | Q92617 | |
| PFSSPLSPLVPPATL | 216 | Q9Y5P3 | |
| LSPLVPPATLLVPYP | 221 | Q9Y5P3 | |
| LPPPDRLLITSSPKP | 2386 | Q96L73 | |
| LLPSVPIESQPPPST | 16 | P34130 | |
| LLPLSRDPSPPLEPL | 196 | Q9H5N1 | |
| PAPITPALAPASLPA | 1071 | O95153 | |
| SIPQPLPPAAPITSL | 126 | Q9NZM3 | |
| PSECLLTPLPPSALP | 266 | Q9UND3 | |
| PDTIDLTLQPPPPVS | 446 | Q13164 | |
| LPSLLSLPATTSPPP | 7096 | Q8WXI7 | |
| PSSPLPVTSLILPGL | 9751 | Q8WXI7 | |
| DLPAPFSPPLTALPT | 326 | P57723 | |
| PVILEIPSLPPSTPP | 571 | Q9BQK8 | |
| PLLFPPLSAPPTLIA | 661 | Q96DN6 | |
| SLTPPAVPPRAPILS | 2056 | P78559 | |
| DILATTPPPVQPPIL | 151 | Q66K74 | |
| PEPVVPTAPELRPST | 1281 | Q14676 | |
| VPQPVLPAPLSAPLS | 561 | Q9UJ55 | |
| SPLRPTPVVAPSEVP | 91 | Q14774 | |
| LPEELSPSPSVLPPS | 416 | O60721 | |
| TSKLDTIPDIPPPRP | 331 | Q13480 | |
| PAPSPVPLPPVLALT | 1036 | O60318 | |
| VPLPPVLALTPSVAP | 1041 | O60318 | |
| ADPVSPPSLPSVPLL | 466 | Q5VYM1 | |
| ILATPESPPPLAPET | 666 | Q9NQC1 | |
| LSPILPDSPVSLPLP | 1001 | Q5SYE7 | |
| SPPPLLLLPESLPGS | 136 | Q5TGS1 | |
| TPPTAALSAPPPLIS | 1211 | Q8WXX7 | |
| LPSPLPATLETPVPA | 356 | P48681 | |
| PSPVPEASPPTPSLL | 991 | Q9UQ05 | |
| PQVTLAPLPLPSPTS | 76 | Q6ZTU2 | |
| TPPECLLTPLPPSAL | 341 | A8MRT5 | |
| SDPPIPVDRTLIPSP | 146 | Q9NZ52 | |
| PECLLTPLPPSALPS | 286 | E9PIF3 | |
| LLTPLPPSAPPSADD | 331 | E9PIF3 | |
| TPPECLLTPLPPSAL | 341 | C9JG80 | |
| SPVPASLAQPPLPVL | 211 | P78563 | |
| SVPPPPLLLPAATTR | 661 | Q8NDX5 | |
| KLPRPAPSLPTDPAL | 21 | O77932 | |
| SPLTGLEAPLLSPPP | 286 | Q9BZI1 | |
| LSPPLDPRALQSPPL | 156 | D6RGH6 | |
| PALPALPAPIPTLLS | 271 | Q99853 | |
| LPSPLLPGSSSPLEP | 231 | Q6V1P9 | |
| LPVAATAPSPAPVLP | 821 | Q86XN7 | |
| TPAPVVPPEPLPSLL | 5106 | Q5VST9 | |
| LPPEVPARPSLTLPA | 456 | Q96JP2 | |
| ISPVLPLVPPPATAL | 446 | Q9HAP2 | |
| TPPEPDPEPLSVVLL | 1271 | Q9BYE9 | |
| TPVLVPLISPPVSPS | 421 | P08887 | |
| PSDTASPLLILPPPV | 441 | Q6Y7W6 | |
| LDFLSRLPLPPPVSP | 3271 | P51587 | |
| PLPPPRALTLAAVTP | 466 | Q9P218 | |
| LSTPSPALICPPNLP | 51 | Q9UJT9 | |
| LSPESPKPTPLTPLE | 141 | Q96JM3 | |
| PSTTEVPPPPRTLLE | 336 | Q6P1N0 | |
| VAPPTVTPVPSLEAP | 341 | P08519 | |
| VAPPTITPIPSLEAP | 911 | P08519 | |
| DLTPTLPETPVPLPR | 1046 | Q9ULH1 | |
| PPNLPILLPSSILPE | 981 | Q6UXX5 | |
| VPLLATPRPTDPIPT | 1841 | Q92538 | |
| LIPIPADSPPPPALS | 1181 | P39059 | |
| GLPLPPTLPSLIPFI | 556 | Q9NSC2 | |
| RPTPPALDPQTEPLI | 81 | P28340 | |
| FPVPTVLSPLPSPVV | 696 | Q96DY7 | |
| TVATPPPPLLPTVPL | 981 | Q13029 | |
| PECLLTPLPPSALPS | 286 | E9PJI5 | |
| LLTPLPPSAPPSADD | 331 | E9PJI5 | |
| PECLLTPLPPSALPS | 286 | P0DM63 | |
| LLTPLPPSAPPSADD | 331 | P0DM63 | |
| LQVLSPLSPLSPEPP | 101 | Q9H987 | |
| TLTPTVLAPRLPQPP | 426 | O00268 | |
| PSLESPTLPPLSSPL | 216 | Q9Y5W9 | |
| EPPSPIEATPPQSLL | 471 | O75151 | |
| RLLEPVPSSPLQPLP | 221 | A6NEV1 | |
| TVAPLPLPATPTPLC | 3221 | A2VEC9 | |
| PDTLIPPPPADASLL | 146 | Q9GZV8 | |
| SPVVPPTEDFLPLPT | 861 | Q6IEE7 | |
| GPLSPSLTTPLPPLD | 141 | Q86TJ2 | |
| SPSLPEPTELPLPPL | 436 | Q9UBS0 | |
| PECLLTPLPPSALPS | 286 | E9PKD4 | |
| ETLLAPPPLPSTPDP | 156 | Q86WR7 | |
| LPLPPTTPPSQELTP | 786 | Q15572 | |
| PPLVSPSLLASPPLQ | 546 | Q9H6K5 | |
| PLTTPPLENLPSLAP | 751 | Q9H6K5 | |
| PPLLPPTSLLKSPLN | 526 | Q9HAZ2 | |
| SPSILPPAPNISVPI | 6 | Q8NGU9 | |
| RSLVPVPSLPPSIPS | 616 | Q96QT6 | |
| EILQDPSPPPLCLPT | 186 | Q5JR12 | |
| VSPPELPPRNIPLTA | 121 | Q92835 | |
| PPLPDSAIFLPPSLD | 1056 | O15357 | |
| TELPLLPPPPSLPTI | 421 | Q9C0A6 | |
| PPFSLTQPLSPVLEP | 766 | Q9H0K1 | |
| PLLPTSIYPVPSLEP | 461 | Q8TF72 | |
| SLEVCPSPRIIPPSP | 741 | Q14940 | |
| PPPPLILSPDLITTL | 191 | Q6ZUB0 | |
| TLTAPLLPIPFPLAP | 456 | Q9H6T0 | |
| PSLLLERPSPEPPAL | 201 | P0DKV0 | |
| LSLAPAPPLAPASPV | 1746 | Q6ZRS2 | |
| PNPITILPVHILPSP | 2471 | Q6ZRS2 | |
| ALTPEPSPTPLPTLP | 1081 | A1L4H1 | |
| SVPSPAPTPFPIELL | 461 | Q9NP71 | |
| LLPSASPLPDPGTPL | 1181 | Q8TAQ2 | |
| ITVSLPPEPADLPLP | 81 | Q92502 | |
| PPPLLAATVLASTPP | 401 | Q7Z6J0 | |
| EVPPVPLPTASSLPR | 1821 | Q9Y566 | |
| SDIAPLPPPVTLVPP | 36 | Q13190 | |
| RELSPLISLPSPVPP | 196 | P51825 | |
| LISLPSPVPPLSPIH | 201 | P51825 | |
| PELPSTPSPVPSPVL | 196 | Q15735 | |
| PAPSEPVLPLLPLPS | 81 | Q5VWI1 | |
| PVLPLLPLPSAPDSA | 86 | Q5VWI1 | |
| SPTPALDPLAPLNPL | 61 | Q1ZZU3 | |
| LPSRPPPLLSPLLAS | 91 | Q86UC2 | |
| PPPPLILSPDLITTL | 191 | P0C874 | |
| IIPLRPLSTPEPPNS | 46 | Q9P243 | |
| PIPTLEPALATESPP | 356 | Q9UPR6 | |
| EATTPTPEPPLPLLP | 1986 | Q9C0A1 | |
| NLTSPSPPVLIPPLR | 1111 | Q6GYQ0 | |
| PPSDPSIPIPTLPSV | 2461 | Q96T58 | |
| SDLPLPLPQPALASP | 421 | Q9NRA0 | |
| PVLASLEPPTPTDLP | 61 | Q8NBB2 | |
| PTAPTKLSPPALLPE | 151 | Q14140 | |
| LPSLAPLVPPPTLLV | 511 | A7XYQ1 | |
| PSATPPEDLILSPRP | 176 | Q6ZQQ2 | |
| KASPPPPLILSPDLI | 191 | Q6ZQQ2 | |
| ELPALPSLPTLPTLP | 296 | Q9BXM0 | |
| PSAPVLVQLPSPPDL | 856 | Q96MS0 | |
| PLPPTLSSYEPLAPL | 191 | Q99594 | |
| VLASAPPLPPSTAAP | 316 | Q6VEQ5 | |
| CLTSLQPLPLPTPPA | 16 | Q8TD17 | |
| APEVLASAPPLPPST | 326 | A8MWX3 | |
| LALTPPLPPLPEASI | 1001 | Q9BX66 | |
| ITAPLPTPLPVEPRL | 3251 | P22105 | |
| VPSPSTLEPHPRPLL | 3691 | P22105 | |
| SPQPLAETPIPSLPE | 681 | Q9HBL0 | |
| VLASAPPLPPSTAAP | 316 | A8K0Z3 | |
| IPTPPPDDPRLSQLL | 146 | Q9NRS6 | |
| APEVLASAPPLPPST | 311 | C4AMC7 | |
| RSLEEILNSIPPPPP | 56 | Q9NTJ3 | |
| SELVALTPAPSVPPP | 696 | P78364 | |
| PPPTPLEESTPVLLS | 786 | Q2M1Z3 | |
| VPLPPEPSLALFAPS | 656 | O43151 | |
| LPTTPAAPGLPPTEI | 606 | Q9P2J2 | |
| LSLTPSPESPPLPDV | 956 | Q96JE7 | |
| PPPTELLDLQPLPVS | 1296 | O75643 | |
| LFTVPAPPPPISSSL | 306 | Q9ULD9 | |
| APPPPISSSLTPQIL | 311 | Q9ULD9 | |
| PDITPLLPVAVPPVS | 611 | Q8N1G0 | |
| EAPVLPLSTEPPAAP | 651 | Q8N1G0 | |
| AAPSPTPLPVQPLSL | 1046 | Q5SXM2 | |
| SLSPELVSTPVPPPP | 201 | Q8N680 | |
| PAVILPSLAAPLPPA | 836 | Q9Y3S1 | |
| PAAVLSPPLPEVLLP | 1046 | Q9Y3S1 | |
| SPPLPEVLLPAAPEL | 1051 | Q9Y3S1 | |
| PEVLASAPPLPPSTA | 296 | Q9NQA3 | |
| PLALSPPRSTPEPDL | 61 | Q8N228 | |
| VPPPLLSPQVPVSLL | 1366 | Q8NDV7 | |
| PAILPVAAPTPVVPS | 1086 | Q9ULM3 | |
| TELFSIPPPATSPLP | 456 | Q8NBT3 | |
| LFPLPPTLPTPVVQL | 306 | P40225 | |
| PTLPTPVVQLHPLLP | 311 | P40225 | |
| LYSTPPTLLPSLLPP | 351 | O75132 | |
| PTLLPSLLPPEGELS | 356 | O75132 | |
| LPVVPSRLPTPATAP | 56 | Q96CT2 | |
| ALETPLSPPPEASPL | 531 | O14686 | |
| PPPEVSRLSPLPVVS | 646 | O14686 | |
| LPVVSRLSPPPEESP | 656 | O14686 | |
| PPLSPLPEELPLSPS | 906 | O14686 | |
| SPLAAPILETPISPP | 971 | O14686 | |
| LAPSPASPPTEPLVE | 4921 | O14686 | |
| LAEPPVPSPLPLASS | 4941 | O14686 | |
| LAPEIPKSVPSPSLP | 726 | E9PAV3 | |
| PPVSLPLAPSPVPTL | 1796 | E9PAV3 | |
| LSPPMPLPQLLPSVT | 561 | O75113 |